Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

TLR9-based immunotherapy for allergic disease.

The American journal of medicine - 1 Oct 2006

Hayashi Tomoko, Raz Eyal

Abstract excerpt

A significant amount of data generated over the last few years supports the contention that Toll-like receptor (TLR) 9-based immunotherapy is effective in the prevention and treatment of animal models of allergic disorders. We will review here our experience with two distinct therapeutic strategies: TLR9-based immunomodulation and TLR9-based vaccination. Immunomodulation of allergic inflammation by TLR9 ligand...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to TLR9 gene
Share to Hypersensitivity
Share to Immunologic Factors

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Immunotherapy

Share to Phenotype

Share to Toll-Like Receptor 9

Share to Vaccines

Source

Identifiers

PMID: 17000223
DOI: 10.1016/j.amjmed.2005.12.028

Genes

TLR9

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

TLR9-based immunotherapy for allergic disease.PMID 17000223Read ↗

Toll‐like receptors: their role in allergy and non‐allergic inflammatory diseaseSemantic proximity Read ↗

Immunobiology of toll-like receptors in allergic diseaseSemantic proximity Read ↗

New insights into innate immune mechanisms underlying allergenicitySemantic proximity Read ↗

MyD88-dependent dendritic and epithelial cell crosstalk orchestrates immune responses to allergensSemantic proximity Read ↗

Differential activation of dendritic cells by toll-like receptors causes diverse differentiation of naïve CD4+ T cells from allergic patients.Semantic proximity Read ↗

Toll-like receptors—novel targets in allergic airway disease (probiotics, friends and relatives)Semantic proximity Read ↗

TL1A priming induces a multi-cytokine Th9 cell phenotype that promotes robust allergic inflammation in murine models of asthma.Semantic proximity Read ↗

A combination TLR7/8 and RIG-I agonist adjuvant reverts asthmatic allergic sensitization and prevents aggravated influenza infection in OVA-sensitized miceSemantic proximity Read ↗

IL-9 is a key component of memory TH cell peanut-specific responses from children with peanut allergySemantic proximity Read ↗

TLR2 regulates neutrophil recruitment and cytokine production with minor contributions from TLR9 during hypersensitivity pneumonitis.Semantic proximity Read ↗

Cysteinyl leukotrienes in allergic inflammation: strategic target for therapy.Semantic proximity Read ↗

Mechanisms underlying the immune response to inhaled house dust miteSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.